Inspire Medical Systems, Inc. (NYSE:INSP) is a top NYSE stock with high upside potential, as per Piper Sandler. The firm lowered Inspire’s price target to $150 from $233, maintaining an Overweight rating following Q2 2025 results. The updated guidance reflects challenges related to the Gen 5 rollout, resulting in significant cuts to top and bottom-line forecasts. Inspire focuses on developing minimally invasive solutions for obstructive sleep apnea, offering innovative therapies. While INSP shows promise, other AI stocks may offer better opportunities. For more insights, check out Insider Monkey’s reports on potential stocks. No disclosure mentioned.

Read more at Yahoo Finance: Piper Sandler Lowers PT on Inspire Medical Systems (INSP) to $150 From $233